Expert Tip from Apexus

img
img

TIP: Master manufacturer refund challenges with actionable steps.


Managing manufacturer refunds in the 340B Drug Pricing Program can be complex, but with the right strategies, you can streamline the process and ensure compliance. Here are some tips to help you navigate common challenges:

  • Allocate Resources Efficiently: When dealing with multiple manufacturers, determine whether an individual or a team will be managing the workload.
  • Prepare Communications: Establish your good-faith process to resolve issues with manufacturers, including the communication protocol, self-disclosure letters, and repayment calculations. Resources such as the PVP Self-Disclosure to HRSA and Manufacturer Template are helpful when developing communications.
  • Validate Historical Pricing: Ensure accurate refund calculations by validating historical drug pricing using resources such as your wholesaler or the Historical Purchase Report within the PVP secure website.
  • Identify Manufacturer Contacts: Use resources like 340B OPAIS and Medicaid.gov to find necessary information.
  • Streamline Payments: Processing multiple check/ACH payments can be cumbersome. Implement a system to manage these transactions efficiently.
  • Use Apexus Experts: Take advantage of the Apexus Covered Entity Refund Service (CRS). CRS brings the expertise of Apexus in 340B compliance, analysis, project management, and reporting to standardize refunds. Streamline the process of refund calculation, documentation, and resolution.

By addressing these challenges proactively, you can enhance the efficiency and accuracy of your 340B program’s refund process. Regularly review and adjust your strategies to ensure ongoing compliance and optimization.

To learn more about the Covered Entity Refund Service, schedule a meeting with one of our experts today.

 

 

Website |  + posts

Read more 340B Expert Tips

« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live